FOLH1 and cancer: On the other hand, late-phase imaging may better fit the slower tracer kinetics of low-PSMA-expressing cancer cells, thus improving diagnostic accuracy in uncertain nodal uptakes at the standard scan, regardless of the reader’s experience.